AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...
Eden Research PLC - Oxfordshire, England-based developer of biopesticides for use in the global crop protection, animal health and consumer products industries - The firm expects to report revenue for ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.
Amarillo Globe-News on MSN1h
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patientsAfter waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
It's also important to remember that some inhalers are meant only for people diagnosed with chronic obstructive pulmonary disease (COPD) and don't treat asthma. These medications include: In many ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
Tradjenta -- A prescription medicine that is used to treat type 2 diabetes. Otezla – A prescription pill that treats plaque ...
Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback